KRW 10680.0
(-2.11%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 5.33 Billion KRW | -17.34% |
2022 | 6.45 Billion KRW | 175.29% |
2021 | 2.34 Billion KRW | -27.55% |
2020 | 3.23 Billion KRW | -2.24% |
2019 | 3.31 Billion KRW | -23.75% |
2018 | 4.34 Billion KRW | 136.83% |
2017 | 1.83 Billion KRW | 4.9% |
2016 | 1.74 Billion KRW | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 5.32 Billion KRW | -5.37% |
2024 Q1 | 5.62 Billion KRW | 5.41% |
2023 Q1 | 5.86 Billion KRW | -9.1% |
2023 Q4 | 5.33 Billion KRW | -20.67% |
2023 Q3 | 6.72 Billion KRW | 22.78% |
2023 Q2 | 5.47 Billion KRW | -6.63% |
2023 FY | 5.33 Billion KRW | -17.34% |
2022 Q3 | 7.1 Billion KRW | 72.83% |
2022 Q4 | 6.45 Billion KRW | -9.18% |
2022 Q1 | 2.33 Billion KRW | -0.43% |
2022 Q2 | 4.11 Billion KRW | 76.15% |
2021 Q3 | 5.57 Billion KRW | 0.0% |
2021 Q4 | 2.34 Billion KRW | -57.97% |
Name | Inventory | Inventory Difference |
---|---|---|
HLB Co., Ltd. | 11.42 Billion KRW | 53.283% |
iNtRON Biotechnology, Inc. | 1.01 Billion KRW | -427.722% |
BINEX Co., Ltd. | 28.26 Billion KRW | 81.12% |
Bioneer Corporation | 41.35 Billion KRW | 87.097% |
Anterogen.Co.,Ltd. | 1.91 Billion KRW | -179.288% |
MEDIPOST Co., Ltd. | 14.51 Billion KRW | 63.244% |
CrystalGenomics, Inc. | 1.55 Billion USD | -243.185% |
Helixmith Co., Ltd | 914.11 Million KRW | -483.715% |
Chabiotech Co.,Ltd. | 34.11 Billion KRW | 84.36% |
Medy-Tox Inc. | 59.61 Billion KRW | 91.05% |
Peptron, Inc. | 172.18 Million KRW | -2998.844% |
Amicogen, Inc. | 46.83 Billion KRW | 88.608% |
Genexine, Inc. | 3.8 Billion KRW | -40.161% |
LegoChem Biosciences, Inc. | 196.83 Million KRW | -2610.816% |
ALTEOGEN Inc. | 1.06 Billion KRW | -399.44% |
PharmaResearch Co., Ltd. | 50.23 Billion KRW | 89.378% |
SillaJen, Inc. | 1.21 Billion KRW | -340.022% |
JETEMA, Co., Ltd. | 12.74 Billion KRW | 58.121% |
OliX Pharmaceuticals,Inc | 468.4 Million KRW | -1039.136% |
Genomictree Inc. | 496.53 Million KRW | -974.618% |
MedPacto, Inc. | 620.00 KRW | -860615714.032% |
D&D Pharmatech | 3.45 Billion KRW | -54.652% |
EASY BIO,Inc. | 25.93 Billion KRW | 79.429% |
GI Innovation, Inc. | - KRW | -Infinity% |